Jin‐Yue Lu

机构：Heilongjiang University of Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College

发表论文 22 篇 · 总被引 282 次 · h-index 9

代表论文

• Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota (2022 · Acta Pharmaceutica Sinica B · 被引 79)
• Hydroxyurea ameliorates atherosclerosis in ApoE -/- mice by potentially modulating Niemann-Pick C1-like 1 protein through the gut microbiota (2022 · Theranostics · 被引 29)
• Gut microbiota-based pharmacokinetic-pharmacodynamic study and molecular mechanism of specnuezhenide in the treatment of colorectal cancer targeting carboxylesterase (2023 · Journal of Pharmaceutical Analysis · 被引 28)
• Gut microbiota-based metabolites of Xiaoyao Pills (a typical Traditional Chinese medicine) ameliorate depression by inhibiting fatty acid amide hydrolase levels in brain (2023 · Journal of Ethnopharmacology · 被引 26)
• Metabolites analysis of plantamajoside based on gut microbiota-drug interaction (2023 · Phytomedicine · 被引 20)
• Gut Microbiota‐Derived Metabolites Orchestrate Metabolic Reprogramming in Diabetic Cardiomyopathy: Mechanisms and Therapeutic Frontiers (2025 · The FASEB Journal · 被引 19)